GrayBella Capital is a growth-stage Venture Capital fund based in London, specializing in pan-European investments. Our strategic focus lies in the HealthTech and Deep Tech sectors, where we actively invest in groundbreaking innovations across various domains.
In HealthTech, we target advancements in digital health, diagnostics, biomarker discovery, MedTech, remote patient monitoring, and platform technologies for drug development.
In the realm of Deep Tech, our investments span material science, robotics, SaaS platforms, and beyond, aiming to support transformative solutions and drive industry-leading growth.
GrayBella Capital will invest between 3 and 15 million euros per company over the life of the investment and will lead or co-lead the financing.
Company Details
- Employees
- 5
- Founded
- -
- Address
- London, Gb
- Industry
- Venture Capital And Private Equity Principals
- NAICS
-
Miscellaneous Intermediation
- Website
- graybellacapital.com
- Keywords
- Technology, diagnostics, AI, Personalised Medicine, Machine Learning, Saas, Cloud Platforms, Venture Capital, Healthcare, analystics, Spain, UK, Lithuania, Latvia, Estonia, Europe.
- HQ
- London
Graybella Capital Questions
Graybella Capital's website is graybellacapital.com
Graybella Capital's LinkedIn profile is https://www.linkedin.com/company/graybella-capital
Graybella Capital has
5 employees.
View email and phone details for 5
employees at Graybella Capital.
Graybella Capital's industry is
Venture Capital and Private Equity Principals
Graybella Capital's top competitors are
Wofford Advisors,
Xenotherapeutics,
Bumi & Space,
Ligo Partners Family Office,
Dunhill Ventures,
Celestial Growth Corp.,
Royc,
Black Toro Capital,
Ucea - Family Office Group,
Spaceflux.
Graybella Capital's categories are Venture Capital and Private Equity Principals
Graybella Capital's founding year is 2019
